Cancer cell discovery could revolutionise treatment
Identification of stem cells enables therapies targeting cells that promote tumour growth
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 02 August 2012
Scientists have discovered direct evidence to support a controversial hypothesis about the growth of cancerous tumours which could revolutionise the diagnosis and treatment of cancer.
The conventional view of cancer is that it results from genetic mutations within ordinary cells that cause them to divide uncontrollably into a tumour that can then spread to other parts of the body. This suggests all cancer cells are created equal with an equal capacity for dividing uncontrollably and an equal tendency to spread. However, three independent studies have now shown this to be a myth.
The scientists found that there is a hierarchy of cancer cells within a solid tumour and at the top of the hierarchy are key "cancer stem cells" that are ultimately responsible for causing a tumour to grow and develop.
Although the existence of cancer stem cells has been postulated for many years, this is the first time that scientists have been able to demonstrate that they exist within solid tumours growing in their natural state, scientists said.
Showing that cancer stem cells exist means that treatments should be focused on killing these cells rather than targeting the wider community of tumour cells, said Luis Parada, of the University of Texas Southwestern Medical Centre in Dallas. "In the past we've tried to get rid of the entire stew of cells within cancer tumours. Now we know that it's a particular bit of the stew that we should try to get rid of," he said.
"Shrinking a tumour by 50 per cent is irrelevant. What you need to know is whether you're targeting the stem cells that allow a tumour to regrow. The good news is that we know what to go after."
The existence of cancer stem cells has been a controversial topic with some specialists rejecting the idea outright. However, in recent years there has been good evidence that they exist for so-called "liquid" tumours, the blood cancers. Now, three independent groups have found direct evidence for cancer stem cells in solid tumours of the brain, skin and digestive system. They have published their findings simultaneously in the journals Nature and Science.
Hugo Snippert, of Utrecht University in the Netherlands, who discovered cancer stem cells in intestinal tumours growing in mice, said the conventional idea of tumours is incorrect.
"Tumour are like caricatures of the tissues from which they were derived. They are composed of different cell types and there is a hierarchy between the types. Like normal tissues have healthy stem cells, tumours have cancer stem cells at the basis of their cellular turnover," Dr Snippert said.
"If we want to treat cancer it is of the utmost importance that the population of cancer stem cells is included in the treatment, otherwise the tumour will grow back."
Dr Parada's work, which was based on studying brain tumours in mice, found that there was a sub-set of tumours cells that grow more slowly than other tumour cells but which allow the tumour continually to replenish itself following treatment with anti-cancer drugs.
Life & Style blogs
GTA 5 Online DLC: San Andreas Flight School update brings 16-seater jet plane and more
What is ALS and the Ice Bucket Challenge?
London restaurant 34 creates champagne glass modelled on Kate Moss’ left breast
Anal sex study reveals climate of 'coercion'
As Kellie Maloney has experienced, when you're transgender, strangers think it's OK to ask intimate questions – it's not
- 1 Jeremy Clarkson 'does not see a problem' with his racist language on Top Gear, says BBC
- 2 Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
- 3 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
- 4 A third of employers never check job applicants' qualifications, survey finds
- 5 James Foley beheading: Fox news presenter Megyn Kelly annoyed by Ferguson update during broadcast about murdered journalist
£25000 - £35000 per annum: Harrington Starr: Junior Quant Analyst - C++, Boost...
£25000 - £35000 per annum: Harrington Starr: Service Desk Analyst- (Desktop Su...
£30000 - £50000 per annum: Harrington Starr: Junior Quant Analyst (Machine Lea...
£45000 - £55000 per annum: Harrington Starr: UNIX Application Support Analyst-...